These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 8448586)

  • 21. Regulation of expression of matrix metalloproteinase-9 in early human T cells of the HSB.2 cultured line by the EP3 subtype of prostaglandin E2 receptor.
    Zeng L; An S; Goetzl EJ
    J Biol Chem; 1996 Nov; 271(44):27744-50. PubMed ID: 8910368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E-ring 8-isoprostanes inhibit ACh release from parasympathetic nerves innervating guinea-pig trachea through agonism of prostanoid receptors of the EP3-subtype.
    Clarke DL; Giembycz MA; Patel HJ; Belvisi MG
    Br J Pharmacol; 2004 Feb; 141(4):600-9. PubMed ID: 14744812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostaglandin E2 differentially modulates human platelet function through the prostanoid EP2 and EP3 receptors.
    Petrucci G; De Cristofaro R; Rutella S; Ranelletti FO; Pocaterra D; Lancellotti S; Habib A; Patrono C; Rocca B
    J Pharmacol Exp Ther; 2011 Feb; 336(2):391-402. PubMed ID: 21059804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Competitive antagonism at thromboxane receptors in human platelets.
    Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
    Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostanoid-induced inhibition of lipolysis in rat isolated adipocytes: probable involvement of EP3 receptors.
    Strong P; Coleman RA; Humphrey PP
    Prostaglandins; 1992 Jun; 43(6):559-66. PubMed ID: 1410520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation.
    Kay LJ; Yeo WW; Peachell PT
    Br J Pharmacol; 2006 Apr; 147(7):707-13. PubMed ID: 16432506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EP receptor subtypes implicated in the PGE2-induced sensitization of polymodal receptors in response to bradykinin and heat.
    Kumazawa T; Mizumura K; Koda H; Fukusako H
    J Neurophysiol; 1996 Jun; 75(6):2361-8. PubMed ID: 8793749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimetics.
    Armstrong RA; Jones RL; MacDermot J; Wilson NH
    Br J Pharmacol; 1986 Mar; 87(3):543-51. PubMed ID: 3026540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EP1- and EP3-receptors mediate prostaglandin E2-induced constriction of porcine large cerebral arteries.
    Jadhav V; Jabre A; Lin SZ; Lee TJ
    J Cereb Blood Flow Metab; 2004 Dec; 24(12):1305-16. PubMed ID: 15625406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PGE(2) reverses G(s)-mediated inhibition of platelet aggregation by interaction with EP3 receptors, but adds to non-G(s)-mediated inhibition of platelet aggregation by interaction with EP4 receptors.
    Glenn JR; White AE; Iyu D; Heptinstall S
    Platelets; 2012; 23(5):344-51. PubMed ID: 22436052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of the inhibitory effects of PGE2 and selective EP agonists on chemotaxis of human neutrophils.
    Armstrong RA
    Br J Pharmacol; 1995 Dec; 116(7):2903-8. PubMed ID: 8680723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel inhibitory prostanoid receptor in piglet saphenous vein.
    Coleman RA; Grix SP; Head SA; Louttit JB; Mallett A; Sheldrick RL
    Prostaglandins; 1994 Feb; 47(2):151-68. PubMed ID: 8016385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A common low-affinity binding site for primary prostanoids on bovine aortic endothelial cells.
    Mazar-Feldman J; Rimon G
    Cell Signal; 1996 Nov; 8(7):497-501. PubMed ID: 9023014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization and ontogeny of PGE2 and PGF2 alpha receptors on the retinal vasculature of the pig.
    Abran D; Li DY; Varma DR; Chemtob S
    Prostaglandins; 1995; 50(5-6):253-67. PubMed ID: 8838237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostaglandin E2 Stimulates EP2, Adenylate Cyclase, Phospholipase C, and Intracellular Calcium Release to Mediate Cyclic Adenosine Monophosphate Production in Dental Pulp Cells.
    Chang MC; Lin SI; Lin LD; Chan CP; Lee MS; Wang TM; Jeng PY; Yeung SY; Jeng JH
    J Endod; 2016 Apr; 42(4):584-8. PubMed ID: 26906242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AH6809, a prostaglandin DP-receptor blocking drug on human platelets.
    Keery RJ; Lumley P
    Br J Pharmacol; 1988 Jul; 94(3):745-54. PubMed ID: 2460179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of noradrenaline release in the rat vena cava via prostanoid receptors of the EP3-subtype.
    Molderings G; Malinowska B; Schlicker E
    Br J Pharmacol; 1992 Oct; 107(2):352-5. PubMed ID: 1330175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro characterization of prostanoid receptors on human myometrium at term pregnancy.
    Senior J; Marshall K; Sangha R; Clayton JK
    Br J Pharmacol; 1993 Feb; 108(2):501-6. PubMed ID: 8448599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
    Krauss AH; Woodward DF; Gibson LL; Protzman CE; Williams LS; Burk RM; Gac TS; Roof MB; Abbas F; Marshall K; Senior J
    Br J Pharmacol; 1996 Mar; 117(6):1171-80. PubMed ID: 8882612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.